On August 12, 2026, Hong Kong's three major indices continued to decline. The Hang Seng Index fell 0.83%, the Hang Seng Tech Index dropped 0.99%, and the Hang Seng China Enterprises Index declined 0.96%.The large‑model sector showed a clear divergence. MINIMAX‑W (00100.HK) was favored by Daiwa and Morgan Stanley, rising nearly 9%, while Z.AI (02513.HK) gained 1.34%.The AI chip and hardware sector staged a broad‑based rebound. MONTAGETECH (06809.HK) and HUA HONG GRACE (01347.HK) both rose over 7%, with SMIC, GIGADEVICE, and others following higher.
NewTimeSpace News: On 12 August 2026, IMPACT THERAP-B (07630.HK) announced the nomination of IMP2794 as a preclinical candidate compound, the first KAT6A-specific PROTAC degrader discovered through its self-owned targeted protein degradation platform, with over 1,000-fold selectivity over KAT6B, excellent in vivo anti-tumour efficacy in breast cancer CDX models and high oral bioavailability.
NewTimeSpace News: On 12 August 2026, BIDU-SW (09888.HK) slipped slightly in the afternoon. As of 15:37, the stock traded at HK$101.80, down 2.68%.
NewTimeSpace (newtimespace.com) reported that on August 12, 2026, the chip theme rebounded, with SMIC (00981.HK) fluctuating higher. As of 13:30, the stock was quoted at HKD 66.700, up 2.14%.
NewTimeSpace News: On 12 August 2026, CH BIOTECH SER (08037.HK) announced that the Company, Pengbo (Hainan) and Stella Pharma entered into a master cooperation agreement on 11 August 2026 for the development and commercialization of Steboronine®, the world's first approved BNCT drug, in China. Upon NMPA approval, Pengbo (Hainan) will act as the exclusive domestic agent and the Company will hold the exclusive general import/distribution right with an initial term of ten years.
NewTimeSpace (newtimespace.com) reported that on August 12, 2026, the robotics theme continued to strengthen, while UBTECH (09880.HK) fluctuated slightly lower. As of 13:13, the stock was quoted at HKD 89.450, down 0.22%.
NewTimeSpace News: On 12 August 2026, LAEKNA-B (02105.HK) announced that the NDA for LAE002 (afuresertib) has been accepted by the Center for Drug Evaluation of the NMPA, for patients with HR+/HER2- locally advanced or metastatic breast cancer harbouring PIK3CA/AKT1/PTEN alterations; the application is based on positive results of the Phase III trial AFFIRM-205, which met its primary endpoint of progression-free survival with statistical significance. The Company entered into an exclusive license agreement with Qilu Pharmaceutical in November 2025 for the China region, with eligibility for upfront and milestone payments of up to RMB 2.045 billion plus tiered royalties.
NewTimeSpace News: On 11 August 2026, BASIC SEMI (09971.HK) announced that the Board considered and approved a proposed application to convert 16,755,283 unlisted domestic shares (representing 5.51% of the total issued shares) into H shares, i.e. full circulation of H shares; the conversion and listing remain subject to the filing notification of the CSRC and the approval of the Stock Exchange. As of the date of the announcement, no application or filing documents have been submitted, and no shareholders' meeting is required for approval.
NewTimeSpace News: On 11 August 2026, COOLPAD GROUP (02369.HK) announced that the Group acquired an aggregate of 24,800 MSTR shares on the open market during the period from 30 July to 10 August 2026 (EST) at a total consideration of approximately USD 2,382,612 (approximately HKD 18,608,200), or approximately USD 96.07 per share, representing approximately 0.01% of MSTR's total outstanding shares after the acquisitions. The acquisitions constitute a discloseable transaction exempt from shareholders' approval and aim to expand the Group's digital currency business.
NewTimeSpace News: CSPC Pharmaceutical Group announced on 11 August that the Phase I clinical trial of SYS6063 developed by the Group for the treatment of relapsed and refractory systemic lupus erythematosus has been officially initiated at the first study site in China.
NewTimeSpace News: The United Laboratories International announced on 11 August that UBT48128 Tablets, a Class 1 innovative drug independently developed by its wholly-owned subsidiary United Biotech, has been granted Investigational New Drug approval by the US FDA.
On August 11, 2026, Hong Kong's three major indices pulled back in volatile trading. The Hang Seng Index fell 1.10%, the Hang Seng Tech Index dropped 1.93%, and the Hang Seng China Enterprises Index declined 1.09%. Total turnover for the day reached HKD 210.9 billion, while Southbound capital recorded a net outflow of HKD 1.376 billion.Most autonomous driving stocks continued to strengthen. PONY‑W (02026.HK) rose 5.75%, leading the sector, after the fourth‑generation Robotruck from Pony.ai officially rolled off the production line. WERIDE‑W (00800.HK) gained 2.55%, with BLACK SESAME and HORIZONROBOT‑W also following higher.
NewTimeSpace News: On 11 August 2026, RoboSense (02498.HK) weakened in the afternoon. As of 15:38, the stock traded at HK$22.96, down 3.53%.
On August 5, Frost & Sullivan and LeadLeo released their 2026 AI Agent report, projecting market growth from RMB 2.6 tn (2025) to 20.1 tn (2030). YouLianCloud's Qilin Financial LLM, the sole finance-focused product, was named to the "Chinese Agents with the Greatest Global Development Potential" list.
NewTimeSpace (newtimespace.com) reported that on August 11, 2026, the chip theme continued to face pressure, with HUA HONG GRACE (01347.HK) fluctuating lower. As of 13:32, the stock was quoted at HKD 133.400, down 2.98%.
NewTimeSpace (newtimespace.com) reported that on August 11, 2026, the robotics theme strengthened in volatile trading, while Midea Group (00300.HK) fluctuated slightly lower. As of 13:14, the stock was quoted at HKD 97.450, down 0.20%.
